This page covers clinically feasible autoimmune skin conditions thesis ideas for MD Dermatology candidates, including psoriasis, vitiligo, alopecia areata, lichen planus, autoimmune blistering disease, cutaneous lupus erythematosus, scleroderma, systemic sclerosis and dermatomyositis that can usually be completed within one thesis period using patients, clinical examination and investigations already available in a dermatology department. The emphasis is on autoimmune skin conditions thesis topics, autoimmune dermatology research topics, autoimmune dermatology protocol and autoimmune dermatology synopsis choices that can be converted into a focused protocol or synopsis without making the project dependent on non-routine resources.
Last reviewed and updated: September 2026 · 2026–27 admissions
Psoriasis
- Clinical and epidemiological profile of chronic plaque psoriasis and its association with disease severity and Dermatology Life Quality Index: a cross-sectional analytical study.
- Correlation of Psoriasis Area and Severity Index with Dermatology Life Quality Index among patients with chronic plaque psoriasis: a cross-sectional study.
- Dermoscopic patterns in chronic plaque psoriasis and their correlation with clinical severity: a cross-sectional analytical study.
- Correlation of dermoscopic findings with routine histopathological features in clinically indicated biopsies of psoriasis: a cross-sectional study.
- Metabolic syndrome and its association with Psoriasis Area and Severity Index among patients with chronic plaque psoriasis: a comparative cross-sectional study.
- Serum lipid abnormalities among patients with chronic plaque psoriasis and their relationship with disease severity: a cross-sectional analytical study.
- Association of body mass index and waist circumference with severity of chronic plaque psoriasis: a cross-sectional analytical study.
- Nail involvement in psoriasis and its correlation with skin disease severity and quality of life: a cross-sectional study.
- Onychoscopic patterns of nail psoriasis and their correlation with clinical nail findings: a cross-sectional analytical study.
- Frequency and clinical pattern of scalp involvement in psoriasis and its association with overall disease severity: a cross-sectional observational study.
- Comparison of clinical characteristics and metabolic comorbidities in early-onset and late-onset psoriasis: a comparative cross-sectional study.
- Prevalence of pruritus in chronic plaque psoriasis and its correlation with disease severity and quality of life: a cross-sectional analytical study.
- Association of smoking, alcohol use and other lifestyle factors with severity of chronic plaque psoriasis: a cross-sectional analytical study.
- Pattern of topical corticosteroid self-medication and inappropriate fixed-dose combination use among patients with psoriasis: a cross-sectional observational study.
- Clinical characteristics and precipitating factors in patients presenting with psoriasis exacerbation: a cross-sectional observational study.
- Comparison of Psoriasis Area and Severity Index and body surface area assessment for grading severity of chronic plaque psoriasis: a comparative cross-sectional study.
- Frequency of psoriatic nail changes and their association with joint symptoms among dermatology patients with psoriasis: a cross-sectional analytical study.
- Predictors of twelve-week clinical response to routinely prescribed systemic therapy in chronic plaque psoriasis: a prospective observational study.
- Adverse effects occurring within twelve weeks of routinely prescribed systemic treatment for psoriasis: a prospective observational study.
- Clinical profile and factors associated with erythrodermic or pustular transformation among hospitalised patients with psoriasis: a retrospective observational study.
Vitiligo
- Clinical and epidemiological profile of vitiligo and its association with Vitiligo Area Scoring Index and Dermatology Life Quality Index: a cross-sectional analytical study.
- Correlation of Vitiligo Area Scoring Index with Dermatology Life Quality Index among adults with vitiligo: a cross-sectional study.
- Dermoscopic patterns of stable and progressive vitiligo: a comparative cross-sectional study.
- Diagnostic utility of dermoscopy in distinguishing vitiligo from other acquired hypopigmentary disorders using clinical diagnosis as the reference standard: a diagnostic accuracy study.
- Wood's lamp findings in vitiligo and their correlation with clinical extent of depigmentation: a cross-sectional analytical study.
- Comparison of clinical and dermoscopic features in segmental and non-segmental vitiligo: a comparative cross-sectional study.
- Thyroid dysfunction among patients with vitiligo and its association with clinical pattern and disease extent: a cross-sectional analytical study.
- Association of family history with age of onset, distribution and extent of vitiligo: a cross-sectional analytical study.
- Frequency and pattern of leukotrichia in vitiligo and its association with disease stability: a cross-sectional study.
- Koebner phenomenon in vitiligo and its relationship with clinical activity: a cross-sectional analytical study.
- Pattern of self-medication and topical corticosteroid misuse among patients with vitiligo: a cross-sectional observational study.
- Comparison of quality-of-life impairment in localised and generalised vitiligo: a comparative cross-sectional study.
- Facial vitiligo: clinical patterns, dermoscopic features and relationship with disease activity: a cross-sectional analytical study.
- Acral vitiligo: clinical and dermoscopic characteristics associated with treatment resistance: a cross-sectional analytical study.
- Childhood-onset versus adult-onset vitiligo: a comparative cross-sectional study of clinical pattern and associated autoimmune disorders.
- Clinical characteristics of mucosal vitiligo and its association with overall disease extent: a cross-sectional observational study.
- Predictors of early repigmentation within twelve weeks of routinely prescribed topical therapy in localised vitiligo: a prospective observational study.
- Early repigmentation patterns following routinely performed punch grafting for stable vitiligo: a prospective observational study.
- Immediate and short-term adverse effects of routinely performed vitiligo surgery within twelve weeks: a prospective observational study.
- Clinical factors associated with stability of vitiligo among patients attending a dermatology outpatient department: a cross-sectional analytical study.
Alopecia Areata
- Clinical and epidemiological profile of alopecia areata and correlation of Severity of Alopecia Tool score with Dermatology Life Quality Index: a cross-sectional analytical study.
- Trichoscopic findings in alopecia areata and their correlation with Severity of Alopecia Tool score: a cross-sectional study.
- Comparison of trichoscopic features in active and stable alopecia areata: a comparative cross-sectional study.
- Diagnostic accuracy of trichoscopy in differentiating alopecia areata from other common non-scarring alopecias using clinical diagnosis as the reference standard.
- Nail changes in alopecia areata and their association with disease severity: a cross-sectional analytical study.
- Thyroid abnormalities in patients with alopecia areata and their association with clinical severity and pattern: a cross-sectional study.
- Association of atopy with clinical pattern and severity of alopecia areata: a cross-sectional analytical study.
- Family history as a predictor of severe clinical phenotype in alopecia areata: a cross-sectional analytical study.
- Comparison of clinical and trichoscopic findings in patchy alopecia areata and alopecia totalis: a comparative cross-sectional study.
- Ophiasis-pattern alopecia areata: clinical characteristics and trichoscopic features in dermatology patients: a cross-sectional observational study.
- Correlation of hair pull test positivity with trichoscopic markers of activity in alopecia areata: a cross-sectional analytical study.
- Quality-of-life impairment in alopecia areata and its relationship with scalp involvement, eyebrow involvement and nail changes: a cross-sectional analytical study.
- Pattern of topical corticosteroid self-medication among patients with alopecia areata: a cross-sectional observational study.
- Comparison of alopecia areata characteristics in paediatric and adult patients attending a dermatology clinic: a comparative cross-sectional study.
- Clinical factors associated with extensive scalp involvement in alopecia areata: a case-control study.
- Trichoscopic predictors of early hair regrowth after routine intralesional corticosteroid therapy in localised alopecia areata: a prospective observational study.
- Early clinical response within twelve weeks to routinely prescribed topical corticosteroid therapy in localised alopecia areata: a prospective observational study.
- Immediate and early adverse effects of routine intralesional corticosteroid therapy for alopecia areata: a prospective observational study.
- Retrospective analysis of clinical patterns and treatment practices in alopecia areata at a tertiary dermatology centre.
- Correlation between duration of alopecia areata and clinical markers of activity and severity: a cross-sectional analytical study.
Lichen Planus
- Clinical and epidemiological profile of cutaneous lichen planus and its impact on Dermatology Life Quality Index: a cross-sectional study.
- Dermoscopic patterns of cutaneous lichen planus and their correlation with clinical morphology: a cross-sectional analytical study.
- Dermoscopic-histopathological correlation in clinically indicated biopsies of cutaneous lichen planus: a cross-sectional study.
- Diagnostic utility of dermoscopy in differentiating lichen planus from common lichenoid dermatoses using clinical and histopathological diagnosis as the reference standard: a diagnostic accuracy study.
- Clinical and dermoscopic characteristics of hypertrophic lichen planus: a cross-sectional observational study.
- Comparison of clinical and dermoscopic features of classical and hypertrophic lichen planus: a comparative cross-sectional study.
- Nail lichen planus: clinical and onychoscopic patterns and their association with cutaneous involvement: a cross-sectional analytical study.
- Scalp involvement in lichen planus: clinical and trichoscopic characteristics of lichen planopilaris: a cross-sectional observational study.
- Oral involvement among patients with cutaneous lichen planus and its association with disease severity: a cross-sectional analytical study.
- Comparison of quality-of-life impairment in generalised and localised cutaneous lichen planus: a comparative cross-sectional study.
- Pruritus severity in lichen planus and its relationship with morphology, extent and quality of life: a cross-sectional analytical study.
- Koebner phenomenon in lichen planus and its association with clinical activity: a cross-sectional study.
- Frequency and pattern of post-inflammatory hyperpigmentation following lichen planus: a cross-sectional observational study.
- Clinical characteristics and associated factors in lichen planus pigmentosus: a cross-sectional analytical study.
- Dermoscopic features of lichen planus pigmentosus and their correlation with distribution and clinical severity: a cross-sectional study.
- Comparison of facial and flexural lichen planus pigmentosus with respect to clinical and dermoscopic patterns: a comparative cross-sectional study.
- Pattern of topical corticosteroid misuse among patients with lichen planus: a cross-sectional observational study.
- Predictors of early clinical response within twelve weeks to routinely prescribed treatment in cutaneous lichen planus: a prospective observational study.
- Retrospective analysis of clinical variants and treatment patterns of lichen planus at a tertiary dermatology centre.
- Clinical factors associated with mucosal involvement among patients with lichen planus: a case-control study.
Pemphigus Vulgaris
- Clinical and epidemiological profile of pemphigus vulgaris and correlation of Pemphigus Disease Area Index with Dermatology Life Quality Index: a cross-sectional analytical study.
- Correlation between oral mucosal involvement and Pemphigus Disease Area Index in pemphigus vulgaris: a cross-sectional study.
- Comparison of clinical severity and quality-of-life impairment in mucocutaneous and predominantly cutaneous pemphigus vulgaris: a comparative cross-sectional study.
- Clinical distribution of lesions in pemphigus vulgaris and its association with overall disease severity: a cross-sectional analytical study.
- Nikolsky sign and its association with Pemphigus Disease Area Index in active pemphigus vulgaris: a cross-sectional analytical study.
- Tzanck smear findings in pemphigus vulgaris and their correlation with clinical activity: a cross-sectional study.
- Diagnostic accuracy of Tzanck smear for suspected pemphigus vulgaris using routine histopathology and clinically indicated immunofluorescence as reference standards.
- Dermoscopic findings in pemphigus vulgaris lesions and their correlation with clinical activity: a cross-sectional observational study.
- Dermoscopic-histopathological correlation in clinically indicated lesions of pemphigus vulgaris: a cross-sectional study.
- Frequency and pattern of secondary cutaneous infections in hospitalised patients with pemphigus vulgaris: a retrospective observational study.
- Association of treatment-related metabolic abnormalities with cumulative corticosteroid exposure recorded in patients with pemphigus vulgaris: a cross-sectional analytical study.
- Pattern of adverse effects among patients receiving routinely prescribed systemic corticosteroids for pemphigus vulgaris: a retrospective observational study.
- Comparison of clinical profile and severity of pemphigus vulgaris in younger and older adults: a comparative cross-sectional study.
- Quality-of-life impairment in pemphigus vulgaris and its relationship with mucosal disease burden: a cross-sectional analytical study.
- Factors associated with extensive oral involvement in pemphigus vulgaris: a case-control study.
- Clinical profile of first presentations of pemphigus vulgaris to a tertiary dermatology centre: a cross-sectional observational study.
- Predictors of early reduction in Pemphigus Disease Area Index within twelve weeks of routinely prescribed therapy: a prospective observational study.
- Early adverse events within twelve weeks of routinely prescribed systemic treatment for pemphigus vulgaris: a prospective observational study.
- Retrospective comparison of clinical characteristics of pemphigus vulgaris patients receiving different established treatment regimens in routine practice.
- Relationship between duration before diagnosis and disease severity at presentation in pemphigus vulgaris: a cross-sectional analytical study.
Bullous Pemphigoid
- Clinical and epidemiological profile of bullous pemphigoid and its impact on Dermatology Life Quality Index: a cross-sectional observational study.
- Clinical severity of bullous pemphigoid and its correlation with quality-of-life impairment: a cross-sectional analytical study.
- Distribution and morphology of lesions in bullous pemphigoid and their relationship with disease severity: a cross-sectional analytical study.
- Frequency and clinical characteristics of mucosal involvement in bullous pemphigoid: a cross-sectional observational study.
- Comparison of bullous pemphigoid with and without mucosal involvement regarding age, extent and clinical severity: a comparative cross-sectional study.
- Tzanck smear findings in suspected bullous pemphigoid and their diagnostic utility against routine histopathology and clinically indicated immunofluorescence: a diagnostic accuracy study.
- Dermoscopic findings in bullous pemphigoid and their correlation with clinical morphology: a cross-sectional study.
- Dermoscopic-histopathological correlation in clinically indicated lesions of bullous pemphigoid: a cross-sectional analytical study.
- Peripheral eosinophilia in bullous pemphigoid and its association with clinical severity: a cross-sectional analytical study.
- Comparison of clinical characteristics of bullous pemphigoid patients with and without peripheral eosinophilia: a comparative cross-sectional study.
- Pattern of secondary cutaneous infection in bullous pemphigoid: a retrospective observational study.
- Frequency and pattern of systemic corticosteroid-related adverse effects among patients treated for bullous pemphigoid: a retrospective observational study.
- Clinical characteristics of bullous pemphigoid in patients aged below and above 70 years: a comparative cross-sectional study.
- Pruritus severity and its relationship with extent of bullous pemphigoid and Dermatology Life Quality Index: a cross-sectional analytical study.
- Factors associated with extensive blistering in bullous pemphigoid: a case-control study.
- Delay in diagnosis of bullous pemphigoid and its association with disease extent at presentation: a cross-sectional analytical study.
- Predictors of early clinical improvement within twelve weeks of routinely prescribed therapy in bullous pemphigoid: a prospective observational study.
- Early adverse events during the first twelve weeks of routine systemic therapy for bullous pemphigoid: a prospective observational study.
- Retrospective analysis of treatment patterns and short-term clinical outcomes among hospitalised patients with bullous pemphigoid.
- Comparison of clinical features of localised and generalised bullous pemphigoid: a comparative cross-sectional study.
Cutaneous Lupus Erythematosus
- Clinical and epidemiological profile of cutaneous lupus erythematosus in patients attending a dermatology department: a cross-sectional observational study.
- Dermoscopic features of discoid lupus erythematosus and their correlation with clinical morphology: a cross-sectional analytical study.
- Dermoscopic-histopathological correlation in clinically indicated lesions of discoid lupus erythematosus: a cross-sectional study.
- Diagnostic utility of dermoscopy in differentiating discoid lupus erythematosus from lichen planus and other common inflammatory facial plaques using routine clinical and histopathological diagnosis as the reference standard.
- Clinical distribution and morphology of discoid lupus erythematosus and their association with scarring and dyspigmentation: a cross-sectional analytical study.
- Comparison of localised and generalised discoid lupus erythematosus with respect to clinical characteristics and quality-of-life impairment: a comparative cross-sectional study.
- Scalp discoid lupus erythematosus: clinical and trichoscopic findings and their correlation with cicatricial alopecia: a cross-sectional study.
- Facial discoid lupus erythematosus: dermoscopic patterns and their relationship with disease duration and scarring: a cross-sectional analytical study.
- Quality-of-life impairment in cutaneous lupus erythematosus and its association with visible-site involvement: a cross-sectional analytical study.
- Photosensitivity and sun-protection practices among patients with cutaneous lupus erythematosus: a cross-sectional observational study.
- Association of smoking with clinical severity of discoid lupus erythematosus: a cross-sectional analytical study.
- Clinical characteristics of patients with cutaneous lupus erythematosus with and without systemic symptoms: a comparative cross-sectional study.
- Frequency of routine haematological abnormalities among dermatology patients with cutaneous lupus erythematosus and their association with clinical subtype: a cross-sectional analytical study.
- Pattern and severity of dyspigmentation in discoid lupus erythematosus and its impact on quality of life: a cross-sectional study.
- Clinical factors associated with scarring alopecia in discoid lupus erythematosus: a case-control study.
- Comparison of dermoscopic features in active and inactive discoid lupus erythematosus lesions: a comparative cross-sectional study.
- Predictors of early clinical improvement within twelve weeks of routinely prescribed topical therapy for localised discoid lupus erythematosus: a prospective observational study.
- Retrospective analysis of clinical patterns and treatment practices in cutaneous lupus erythematosus at a tertiary dermatology centre.
- Relationship between diagnostic delay and scarring severity in discoid lupus erythematosus: a cross-sectional analytical study.
- Clinical and dermoscopic predictors of established scarring in discoid lupus erythematosus: a cross-sectional analytical study.
Localised Scleroderma and Cutaneous Systemic Sclerosis
- Clinical and epidemiological profile of localised scleroderma in dermatology patients: a cross-sectional observational study.
- Clinical patterns of morphea and their association with disease extent and functional limitation: a cross-sectional analytical study.
- Dermoscopic features of morphea and their correlation with clinical activity: a cross-sectional study.
- Dermoscopic-histopathological correlation in clinically indicated biopsies of morphea: a cross-sectional analytical study.
- Comparison of dermoscopic features in active inflammatory and inactive sclerotic morphea lesions: a comparative cross-sectional study.
- Clinical factors associated with extensive morphea: a case-control study.
- Quality-of-life impairment among patients with localised scleroderma and its association with visible-site involvement: a cross-sectional analytical study.
- Clinical profile of linear morphea and frequency of functional impairment among dermatology patients: a cross-sectional observational study.
- Comparison of plaque morphea and linear morphea with respect to demographic, clinical and dermoscopic characteristics: a comparative cross-sectional study.
- Clinical and dermoscopic characteristics of facial morphea: a cross-sectional study.
- Clinical spectrum of cutaneous manifestations in systemic sclerosis patients attending a dermatology clinic: a cross-sectional observational study.
- Nailfold and periungual clinical changes in systemic sclerosis and their association with cutaneous disease extent: a cross-sectional analytical study using routine dermoscopy.
- Pigmentary changes in systemic sclerosis and their relationship with cutaneous involvement and quality of life: a cross-sectional analytical study.
- Frequency and pattern of digital ulcers in systemic sclerosis patients attending dermatology services: a cross-sectional observational study.
- Factors associated with digital ulceration among patients with systemic sclerosis: a case-control study.
- Clinical characteristics of calcinosis cutis in systemic sclerosis and its association with disease duration and digital changes: a cross-sectional analytical study.
- Comparison of cutaneous findings in limited and diffuse systemic sclerosis: a comparative cross-sectional study.
- Pruritus in systemic sclerosis and its relationship with cutaneous involvement and quality of life: a cross-sectional analytical study.
- Retrospective analysis of dermatological manifestations and treatment patterns in systemic sclerosis at a tertiary centre.
- Predictors of short-term improvement in active morphea within twelve weeks of routinely prescribed therapy: a prospective observational study.
Dermatomyositis
- Clinical and epidemiological profile of cutaneous manifestations in dermatomyositis patients attending a dermatology department: a cross-sectional observational study.
- Frequency and distribution of Gottron papules, heliotrope rash and other characteristic cutaneous signs in dermatomyositis: a cross-sectional study.
- Dermoscopic features of Gottron papules and their correlation with clinical morphology: a cross-sectional analytical study.
- Dermoscopic-histopathological correlation in clinically indicated cutaneous lesions of dermatomyositis: a cross-sectional study.
- Scalp involvement in dermatomyositis: clinical and trichoscopic characteristics: a cross-sectional observational study.
- Comparison of scalp dermatomyositis and scalp psoriasis with respect to clinical and trichoscopic findings: a comparative cross-sectional study.
- Nailfold and periungual dermoscopic changes in dermatomyositis and their association with cutaneous disease burden: a cross-sectional analytical study.
- Photosensitivity and photoprotective practices among patients with cutaneous dermatomyositis: a cross-sectional observational study.
- Pruritus in dermatomyositis and its correlation with extent of cutaneous involvement and quality of life: a cross-sectional analytical study.
- Quality-of-life impairment in dermatomyositis and its association with facial and scalp involvement: a cross-sectional analytical study.
- Clinical characteristics of calcinosis cutis among patients with dermatomyositis: a cross-sectional observational study.
- Comparison of patients with dermatomyositis with and without calcinosis cutis regarding cutaneous phenotype and disease duration: a comparative cross-sectional study.
- Clinical factors associated with ulcerative cutaneous lesions in dermatomyositis: a case-control study.
- Pattern of dyspigmentation in chronic dermatomyositis and its association with disease duration: a cross-sectional analytical study.
- Frequency of routine haematological and biochemical abnormalities among dermatology patients with dermatomyositis and their association with cutaneous severity: a cross-sectional analytical study.
- Comparison of cutaneous manifestations in adult and juvenile dermatomyositis patients attending dermatology services: a comparative cross-sectional study.
- Retrospective analysis of dermatological manifestations and treatment patterns in dermatomyositis at a tertiary centre.
- Predictors of early cutaneous improvement within twelve weeks of routinely prescribed treatment in dermatomyositis: a prospective observational study.
- Early treatment-related cutaneous adverse effects in dermatomyositis within twelve weeks of routine therapy: a prospective observational study.
- Relationship between delay in dermatological diagnosis and extent of cutaneous involvement in dermatomyositis: a cross-sectional analytical study.
Autoimmune Blistering and Other Autoimmune Dermatoses
- Clinical profile of pemphigus foliaceus and its association with disease extent and Dermatology Life Quality Index: a cross-sectional analytical study.
- Dermoscopic findings in pemphigus foliaceus and their correlation with clinical morphology: a cross-sectional study.
- Diagnostic accuracy of Tzanck smear in pemphigus foliaceus using routine histopathology and clinically indicated immunofluorescence as reference standards.
- Comparison of clinical characteristics and quality-of-life impairment in pemphigus foliaceus and pemphigus vulgaris: a comparative cross-sectional study.
- Clinical and epidemiological profile of dermatitis herpetiformis among dermatology patients: a retrospective observational study.
- Dermoscopic patterns in dermatitis herpetiformis and their correlation with clinical morphology: a cross-sectional observational study.
- Clinical profile of linear immunoglobulin A bullous dermatosis presenting to a tertiary dermatology centre: a retrospective observational study.
- Comparison of clinical characteristics of linear immunoglobulin A bullous dermatosis and bullous pemphigoid in adults: a comparative retrospective study.
- Clinical spectrum and quality-of-life impact of autoimmune bullous diseases in a tertiary dermatology centre: a cross-sectional observational study.
- Factors associated with mucosal involvement across autoimmune bullous diseases: a case-control study.
- Pattern of ocular and oral symptoms already documented during routine care in patients with autoimmune blistering disorders: a retrospective observational study.
- Clinical factors associated with secondary bacterial infection in autoimmune blistering diseases: a case-control study.
- Diagnostic utility of Tzanck smear in common autoimmune vesiculobullous disorders using routine clinicopathological diagnosis as the reference standard: a diagnostic accuracy study.
- Comparison of clinical morphology, Nikolsky sign and Tzanck smear findings in pemphigus vulgaris, pemphigus foliaceus and bullous pemphigoid: a comparative cross-sectional study.
- Quality-of-life impairment across common autoimmune blistering diseases and its correlation with skin and mucosal involvement: a cross-sectional analytical study.
- Pattern of systemic corticosteroid-related cutaneous adverse effects in patients with autoimmune blistering diseases: a cross-sectional observational study.
- Clinical and dermoscopic profile of lichen sclerosus at routinely examined non-genital sites: a cross-sectional observational study.
- Extragenital lichen sclerosus: correlation of dermoscopic findings with routine histopathology in clinically indicated biopsies: a cross-sectional study.
- Clinical factors associated with extensive extragenital lichen sclerosus: a case-control study.
- Early clinical response within twelve weeks to routinely prescribed therapy in common autoimmune blistering dermatoses: a prospective observational study.
Not the dermatology subspeciality you need? Autoimmune skin conditions is one section of our full dermatology collection — the hub page lists every subspeciality, each with its own free topic list. Updated September 2026.
Browse all Dermatology Thesis Topics →
📌 Updated for 2026–2027 MD Dermatology Autoimmune Skin Conditions admissions
The proposed designs were reviewed for feasibility across common autoimmune dermatoses, with particular attention to disease-specific severity scoring, dermoscopy, histopathology, immunofluorescence and routine treatment follow-up.
- Most topics can be completed with clinical examination, validated disease-specific scores, dermoscopy or trichoscopy, routine laboratory tests and histopathology or immunofluorescence when already clinically indicated.
- Advanced autoantibody panels, molecular testing, repeated research-only biopsy and specialised imaging are generally not required for a feasible residency project.
- Publication potential is strongest when the disease definition, reference standard, severity measure and biopsy pathway are fixed before enrolment.
Generate a protocol from any topic above
Select Generate Protocol → beside any title in the list above and receive a submission-ready document built around that topic, containing all eighteen components:
- Introduction / Synopsis
- Research Question
- Aim of the Study
- Primary Objective
- Secondary Objectives
- Materials and Methods
- Inclusion Criteria
- Exclusion Criteria
- Sample Size Calculation
- Methodology
- Statistical Analysis
- Ethical Considerations
- Review of Literature
- References
- Gantt Chart / Study Timeline
- Patient Information Sheet
- Consent Form
- Data Collection Form
Already have your thesis title?
Generate the full autoimmune skin conditions protocol directly — objectives, methodology, sample size, statistics, timeline, references and annexures.
Generate your protocol
Alongside autoimmune skin conditions protocols and synopses, support is also available for departmental presentations, journal club presentations, ethics committee presentations, and posters and oral presentations for medical conferences — for postgraduate residents, board trainees and research scholars across India and the GCC. Prepared by a practising doctor with long experience in medical publishing and thesis supervision.
Enquire on WhatsApp →
Autoimmune skin conditions research outside India
The topics above work as research questions anywhere — what changes is the document the institution expects, and who approves it before data collection begins. The Gulf equivalent of an Indian synopsis is the autoimmune skin conditions research proposal submitted to an institutional review board, and it ordinarily carries three sections an Indian synopsis does not: a Gantt chart, a budget and resources section, and a Declaration of Helsinki statement.
Board and residency programmes — country by country
Saudi Arabia — SCFHS and the Saudi Board. Residency and fellowship training under the Saudi Commission for Health Specialties includes a research project with a set timeline, and the autoimmune skin conditions research proposal is the document prepared at the outset and cleared by the institutional review board before recruitment starts.
United Arab Emirates — DHA, DOH Abu Dhabi and MOHAP. Residents training in Dubai, Abu Dhabi and the northern emirates prepare an autoimmune skin conditions research protocol for their programme and submit it for institutional review board approval before any data are collected.
Qatar — DHP (formerly QCHP) and Hamad Medical Corporation. A autoimmune skin conditions IRB proposal is reviewed before recruitment, with the ethics section written to the institution's own template rather than a generic one.
Bahrain — NHRA. Trainees turning autoimmune skin conditions research topics into a project need the proposal cleared by their institutional research and ethics committee before fieldwork begins.
Oman — OMSB. Residency programmes under the Oman Medical Specialty Board include a research component, and the autoimmune skin conditions research proposal is the document assessed at the start of it.
Kuwait — KIMS. A autoimmune skin conditions study protocol goes to the institutional committee for approval before the project begins.
Arab Board programmes across the region. The Arab Board carries its own research requirement irrespective of the host country, and the autoimmune skin conditions proposal follows the same structure throughout.
Postgraduate degrees — Malaysia, the Gulf and beyond
Malaysia — MMed, the National Medical Research Register and MREC. A autoimmune skin conditions dissertation proposal for a Master of Medicine programme carried out in a Ministry of Health facility must be registered on the NMRR and approved by the Medical Research and Ethics Committee before the study begins, and the guidance asks for submission four to six months ahead of data collection. Every investigator on the study team registers on the NMRR as well, so the methodology, ethics and team sections are written in far more detail than an Indian synopsis requires.
PhD and Master's candidates elsewhere. University programmes generally require a full autoimmune skin conditions research proposal of roughly 6,000 to 10,000 words, with an extended literature review, a theoretical framework and a detailed methodology chapter.
PhD and MMed proposals are written individually by a medical doctor and revised until the supervisor accepts them. They are not produced by the automated protocol generator.
Enquire about an autoimmune skin conditions PhD or MMed proposal →
🔥 Trending research areas in Autoimmune Skin Conditions for 2026–27
- Dermoscopy and trichoscopy are increasingly useful for non-invasive assessment of inflammatory activity, particularly when studies clearly separate correlation from diagnostic accuracy.
- Clinicopathological and immunofluorescence concordance remains important in autoimmune blistering disease because lesion selection and specimen handling strongly influence diagnostic yield.
- Disease-specific quality-of-life research is valuable because visible-site involvement, mucosal disease, scarring, dyspigmentation and permanent hair loss may produce morbidity that is not captured by extent scores alone.
- Real-world treatment response and adverse-effect studies remain relevant because systemic corticosteroids and immunomodulatory therapies produce clinically important short-term benefits and toxicities that can be measured within routine follow-up.
Protocol and synopsis guidance
What an autoimmune skin conditions protocol must contain
An autoimmune dermatology protocol should define the exact disease entity or biologically coherent comparison group rather than treating all autoimmune dermatoses as one category. Psoriasis, vitiligo, alopecia areata, lichen planus, pemphigus, bullous pemphigoid, cutaneous lupus, morphea, systemic sclerosis and dermatomyositis require different diagnostic and severity frameworks.
Diagnosis and reference standard: State whether diagnosis is based on clinical examination, dermoscopy, trichoscopy, histopathology, direct immunofluorescence, serology or a predefined composite. If diagnostic accuracy is claimed, the reference standard must be independent of the index test and applied as consistently as possible.
Disease activity and severity: PASI, VASI, SALT, PDAI and other disease-specific scores are not interchangeable. The protocol should fix the score, assessor, anatomical sites and time-point before enrolment and should distinguish activity from accumulated damage such as scarring, dyspigmentation or permanent alopecia.
Biopsy and immunofluorescence: Lesion selection matters. Routine histopathology and direct immunofluorescence may require different biopsy sites, and sampling an eroded, infected or inactive lesion can reduce diagnostic yield. The protocol should state the biopsy site, specimen handling and how discordant clinicopathological results will be resolved.
Autoimmune skin conditions synopsis versus autoimmune skin conditions protocol
The synopsis gives the academic committee the research question, rationale, objectives, study design, broad methods, sample size, statistical approach and ethics in concise form. It should establish that the proposed project is feasible with the available patient load and diagnostic pathway.
The full protocol must define disease-specific criteria that the synopsis may only summarise. It should specify the exact severity or activity scale, lesion selection for dermoscopy or biopsy, histopathology and immunofluorescence methods where relevant, definitions of mucosal or systemic involvement and the rules for treatment exposure and follow-up.
For comparative or diagnostic studies, the protocol should also explain blinding, verification of negative cases and handling of discordant results. These details are essential because autoimmune dermatology studies can appear methodologically sound while still producing biased estimates if confirmatory testing is restricted to selected patients.
Sample size and statistical analysis
Sample size should be based on the primary objective and the specific autoimmune disease being studied. Prevalence or profile studies need an expected proportion and precision; comparative studies need an anticipated between-group difference; case-control studies need an expected exposure difference; and prospective response studies need an expected change in the predefined disease-specific outcome.
Severity scores should be analysed according to their scale and distribution. Correlation between a clinical score and dermoscopic or histopathological findings does not establish diagnostic accuracy. Agreement between observers or methods may require kappa or an intraclass correlation coefficient depending on the data type.
For diagnostic studies, sensitivity and specificity require an appropriate reference standard in both positive and negative arms. If only selected patients undergo biopsy or immunofluorescence, partial verification should be acknowledged and interpreted cautiously. Multivariable models should remain realistic for the available sample and avoid excessive predictors in uncommon diseases.
Frequently Asked Questions – Autoimmune Skin Conditions Thesis Topics (2026–27)
1. How should I choose a feasible autoimmune skin conditions thesis topic for 2026–2027 MD Dermatology admissions?
Choose one clearly defined autoimmune dermatosis or a tightly related disease group that matches the department's case-load and routine diagnostic facilities. Feasible projects commonly use clinical examination, disease-specific severity scores, dermoscopy, trichoscopy, onychoscopy, routine laboratory tests, histopathology and immunofluorescence only when clinically indicated. Avoid combining unrelated autoimmune diseases under one outcome unless the research question genuinely requires a comparative design.
2. Which study designs are suitable for autoimmune skin conditions research?
Cross-sectional observational and analytical designs suit clinical profiling, severity correlations, quality of life, dermoscopic findings and associated comorbidities. Comparative cross-sectional studies are useful for clinically overlapping conditions or disease subtypes. Case-control studies can examine factors associated with severe disease, scarring, mucosal involvement, digital ulceration or extensive blistering. Prospective observational studies are suitable for early response, adverse effects and routine treatment outcomes.
3. What should I settle with my guide before finalising an autoimmune skin conditions protocol?
Define the exact disease, diagnostic criteria, activity or severity instrument, primary outcome, biopsy or immunofluorescence pathway and treatment exposure before recruitment begins. The protocol should state whether diagnosis is clinical, histopathological, immunofluorescence-based or composite, and should explain how borderline or discordant cases will be handled. If serial photographs or dermoscopy are used, acquisition and assessment methods should also be fixed in advance.
4. How should rare autoimmune dermatoses be handled in a thesis?
Rare conditions are often better studied with retrospective cohorts, descriptive case series, pooled clinicopathological data or broader but biologically coherent disease groups rather than an underpowered prospective comparison. The inclusion period can be extended if records are reliable. The protocol should avoid creating artificial statistical comparisons from very small subgroups and should state clearly when the study is descriptive rather than inferential.
5. What is the difference between an autoimmune dermatology synopsis and protocol?
The synopsis is the concise academic submission containing the research question, rationale, objectives, design, sample size, broad methods, statistical plan and ethics. The full protocol is the operational document and should specify disease definitions, severity scales, lesion selection, biopsy technique, immunofluorescence handling, laboratory criteria, treatment exposure, follow-up windows and analysis rules in enough detail for another investigator to reproduce the study.
6. What ethical issues should an autoimmune skin disease thesis address?
For children, guardian consent and child assent from about seven years should be addressed according to institutional policy. Record-based work may seek a consent waiver where permitted. No additional biopsy, immunofluorescence, blood sampling or systemic treatment should be added purely for research unless specifically justified and approved, and any research-only venepuncture should state a blood volume limit. Separate consent should cover identifiable clinical photographs and video. The protocol should also define escalation pathways for important findings such as severe mucosal disease, ocular involvement, suspected systemic lupus, progressive systemic sclerosis, severe infection, treatment toxicity or rapidly worsening blistering disease.
7. What is the sharpest methodological problem in autoimmune skin conditions research?
The sharpest problem is using a non-independent reference standard. Clinical morphology, dermoscopy, histopathology, direct immunofluorescence and serology are related but not interchangeable. If only selected or severe cases undergo biopsy or immunofluorescence, diagnostic accuracy estimates become biased. The protocol should specify which test establishes diagnosis, how biopsy sites are selected, how discordant results are adjudicated and what happens to clinically suspected cases that do not receive confirmatory testing.
8. Can an autoimmune skin disease topic be adapted for PhD, Saudi Board, Arab Board or Gulf research requirements?
Yes. An MD synopsis usually addresses a focused clinical question that can be completed within residency, whereas a PhD proposal requires a broader conceptual framework, deeper methodological justification and a programme of work. Board pathways may also require a separate research project, including SCFHS and Saudi Board requirements, the Arab Board of Health Specializations, and research components linked to DHP, DHA, DOH and MOHAP training programmes. The core dermatology question can often be retained, but governance, sample size, laboratory methods and expected outputs should be adapted to the relevant institution or board.
9. When should I register my autoimmune dermatology thesis?
Registration and institutional approvals should be completed before prospective recruitment or study-specific data collection begins. The final protocol, diagnostic criteria, severity score, biopsy and immunofluorescence pathway, treatment exposure definitions and statistical plan should be settled first. Retrospective studies should clarify ethics approval and access to identifiable records, images and pathology data before extraction.
Found a topic that fits your department?
Generate its full protocol — objectives, methodology, sample size, statistics, timeline, references and annexures — in editable format.
Generate your protocol
